ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
bullish•Crude Oil
•03 Apr 2023 10:24•Broker

Today's Dominant Ideas

The SET Index is expected to weaken, with the support at 1,600/1,590 points and the resistance at 1,618/1,625 points. Regarding the investment...

Logo
86 Views
Share
•30 Nov 2022 14:40•Broker

Stronger Baht and More Attractive Valuation to Boost the SET

The baht may gain further on the expectation that the MPC will raise its policy interest rate on Nov. 30. The market risk premium (MRP) is likely...

Logo
91 Views
Share
•12 Oct 2022 10:37•Broker

Market Outlook

The SET Index is expected to move sideways down, with the resistance at 1,569/1,580 points and the support at 1,556/1,550 points. We recommend...

Logo
90 Views
Share
•11 Oct 2022 10:42•Broker

Market Outlook and Recommendations

The SET Index is expected to move sideways down, with the resistance at 1,580/1,588 points and the support at 1,562/1,556 points. Negative...

Logo
88 Views
Share
•19 Sep 2022 11:07•Broker

Market Outlook

The SET Index is expected to move sideways down, with the resistance at 1,650/1,660 points and the support at 1,620/1,610 points. Technically, the...

Logo
90 Views
Share
x